MMED MiniMed Group, Inc. - Common Stock

NASDAQ · · 在 SEC EDGAR 上查看 ↗
$15.59
价格 · 七月 2, 2026
截至...的财报数据 六月 29, 2026
52周区间
$11–$16
96% of range
分析师评级
BUY
15 analysts
目标价
$21
+34% upside
P/E (TTM)
-10.2
ROE
-9.3%
净利润率
-10.7%

MMED 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

价格
$15.59
市值
$3.71B
P/E (TTM)
-10.2
每股收益 (TTM)
$-1.30
营收 (TTM)
$3.10B
股息收益率
—
ROE
-9.3%
负债/权益
—
52周区间
$11 – $16

MMED 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

10年表现 收入、净利润、利润率和每股收益趋势

营收与净利润 $3.10B
3-point trend, +25.6%
2024-04-26 → 2026-04-24
EPS $-1.30
3-point trend, -195.5%
2024-04-26 → 2026-04-24
自由现金流 $-420M
2026-04-24 → 2026-04-24
利润率 -10.7%
2026-04-24 → 2026-04-24

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？

指标
5年趋势
MMED
同行中位数
P/E (TTM)
-10.2
—
P/S (TTM) (市销率 (TTM))
1.2
—
P/B (市净率)
1.0
—
Price / FCF (股价/自由现金流)
-8.8
—

盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)

指标
5年趋势
MMED
同行中位数
Gross Margin (毛利率)
54.2%
—
Operating Margin (营业利润率)
-6.1%
—
Net Profit Margin (净利润率)
-10.7%
—
ROA
-7.5%
—
ROE
-9.3%
—
ROIC
-8.8%
—

财务健康 债务、流动性、偿付能力 — 资产负债表强度

指标
5年趋势
MMED
同行中位数
Current Ratio (流动比率)
1.9
—
Quick Ratio (速动比率)
0.7
—

成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)

指标
5年趋势
MMED
同行中位数
Revenue YoY (营收同比增长)
3-point trend, +25.6%
14.2%
—

每股指标 每股收益 (EPS)、每股净资产、每股现金流、每股股息

指标
5年趋势
MMED
同行中位数
EPS (Diluted) (EPS (稀释))
3-point trend, -195.5%
$-1.30
—

资本效率 资产周转率、库存周转率、应收账款周转率

指标
5年趋势
MMED
同行中位数

MMED 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

买入 15 位分析师
  • 强烈买入 5 33.3%
  • 买入 8 53.3%
  • 持有 2 13.3%
  • 卖出 0 0.0%
  • 强烈卖出 0 0.0%

12个月价格目标

11 位分析师 · 2026-07-01
中位数目标 $20.00 +28.3%
平均目标 $20.91 +34.1%

收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期

平均惊喜
-0.57%
期间 EPS Actual EPS 预期 惊喜
2026年12月31日 $-0.68 $-0.17 —
2026年6月30日 $-0.68 $-0.17 -0.51%
2026年3月31日 $-0.47 $0.16 -0.63%

同行比较 关键指标与行业同行对比

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
MMED $3.71B -10.2 14.2% -10.7% -9.3% 54.2%
MDLN — -4200.0 11.5% 4.1% 21.6% 26.4%
COO $13.70B 37.4 5.1% 9.2% 4.6% 65.5%
SOLV $13.75B 8.9 0.86% 18.7% 35.8% 53.5%
ALGN $11.14B 27.6 0.90% 10.2% 10.3% 67.2%
LNTH $4.30B 19.5 0.50% 15.2% 20.7% 61.1%
MMSI $5.24B 41.4 11.8% 8.5% 8.4% 48.7%
QDEL $1.99B -1.8 -1.9% -41.4% -48.0% —
ICUI $3.52B 4755.7 -6.3% 0.03% 0.03% 36.8%
HAE $2.45B 26.4 -2.0% 7.3% 11.8% 59.0%
UFPT $1.71B 25.4 19.5% 11.3% 16.9% 28.3%

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

损益表 14
MMED 的年度损益表数据
指标 趋势 20262025
Revenue 2-point trend, +14.3% $3.10B $2.71B
Cost of Revenue 2-point trend, +19.8% $1.42B $1.19B
Gross Profit 2-point trend, +9.9% $1.68B $1.53B
SG&A Expense 2-point trend, +9.5% $1.18B $1.08B
Operating Income 2-point trend, -30.1% $-190M $-146M
Other Non-op 2-point trend, +200.0% $1M $-1M
Pretax Income 2-point trend, -28.6% $-189M $-147M
Income Tax 2-point trend, +146.2% $128M $52M
Net Income 2-point trend, -56.3% $-333M $-213M
EPS (Basic) 2-point trend, -54.8% $-1.30 $-0.84
EPS (Diluted) 2-point trend, -54.8% $-1.30 $-0.84
Shares (Basic) 2-point trend, +1.5% 256,600,000 252,800,000
Shares (Diluted) 2-point trend, +1.5% 256,600,000 252,800,000
EBITDA $-34M ·
资产负债表 24
MMED 的年度资产负债表数据
指标 趋势 20262025
Cash & Equivalents 2-point trend, +2609.1% $298M $11M
Receivables 2-point trend, -64.9% $200M $570M
Inventory 2-point trend, +9.6% $341M $311M
Other Current Assets 2-point trend, +12.5% $54M $48M
Current Assets 2-point trend, +43.6% $1.35B $939M
PP&E (Net) 2-point trend, +0.7% $711M $706M
PP&E (Gross) 2-point trend, +9.0% $1.49B $1.37B
Accum. Depreciation 2-point trend, +17.8% $781M $663M
Goodwill 2-point trend, +0.0% $2.26B $2.25B
Intangibles 2-point trend, -18.9% $107M $132M
Other Non-current Assets 2-point trend, -2.0% $147M $150M
Total Assets 2-point trend, +10.2% $4.63B $4.20B
Accounts Payable 2-point trend, -20.5% $163M $205M
Current Liabilities 2-point trend, -1.1% $702M $710M
Capital Leases 2-point trend, -19.6% $45M $56M
Other Non-current Liabilities 2-point trend, +95.7% $317M $162M
Total Liabilities 2-point trend, +17.0% $1.02B $871M
Common Stock 2-point trend, +3000000.00 $3M $0
Paid-in Capital 2-point trend, +3736000000.00 $3.74B $0
Retained Earnings 2-point trend, -116000000.00 $-116M $0
AOCI 2-point trend, -500.0% $-12M $3M
Stockholders' Equity 2-point trend, +8.4% $3.61B $3.33B
Liabilities + Equity 2-point trend, +10.2% $4.63B $4.20B
Shares Outstanding 2-point trend, +280819988.00 280,819,988 0
现金流 12
MMED 的年度现金流数据
指标 趋势 20262025
D&A 2-point trend, +9.1% $156M $143M
Stock-based Comp 2-point trend, +12.2% $46M $41M
Deferred Tax 2-point trend, -2400.0% $-50M $-2M
Amort. of Intangibles 2-point trend, -10.3% $26M $29M
Other Non-cash $-16M ·
Operating Cash Flow 2-point trend, -240.7% $-197M $140M
CapEx 2-point trend, +15.5% $223M $193M
Investing Cash Flow 2-point trend, -20.7% $-233M $-193M
Financing Cash Flow 2-point trend, +7060.0% $716M $10M
Net Change in Cash 2-point trend, +767.4% $287M $-43M
Taxes Paid 2-point trend, +2000000.00 $2M $0
Free Cash Flow $-420M ·
盈利能力 8
MMED 的年度盈利能力数据
指标 趋势 20262025
Gross Margin 54.2% ·
Operating Margin -6.1% ·
Net Margin -10.7% ·
Pretax Margin -6.1% ·
EBITDA Margin -1.1% ·
ROA -7.5% ·
ROE -9.3% ·
ROIC -8.8% ·
流动性与偿付能力 2
MMED 的年度流动性与偿付能力数据
指标 趋势 20262025
Current Ratio 1.9 ·
Quick Ratio 0.7 ·
效率 3
MMED 的年度效率数据
指标 趋势 20262025
Asset Turnover 0.7 ·
Inventory Turnover 4.4 ·
Receivables Turnover 8.1 ·
每股 5
MMED 的年度每股数据
指标 趋势 20262025
Book Value / Share $12.86 ·
Revenue / Share $12.09 ·
Cash Flow / Share $-0.77 ·
Cash / Share $1.06 ·
EPS (TTM) $-1.30 ·
增长率 1
MMED 的年度增长率数据
指标 趋势 20262025
Revenue YoY 2-point trend, +43.1% 14.2% 10.0%
估值 (TTM) 10
MMED 的年度估值 (TTM)数据
指标 趋势 20262025
Revenue TTM $3.10B ·
Net Income TTM $-333M ·
Market Cap $3.71B ·
P/E -10.2 ·
P/S 1.2 ·
P/B 1.0 ·
P / Tangible Book 3.0 ·
P / Cash Flow -18.8 ·
P / FCF -8.8 ·
Earnings Yield -9.8% ·

财务报表 损益表、资产负债表、现金流量表 — 年度，近5年

损益表
2026-04-242025-04-252024-04-26
收入 $3.10B$2.71B$2.47B
毛利率 % 54.2%——
营业利润率 % -6.1%——
净收入 $-333M$-213M$-112M
稀释后每股收益 (EPS) $-1.30$-0.84$-0.44
资产负债表
2026-04-242025-04-252024-04-26
流动比率 1.9——
速动比率 0.7——
现金流
2026-04-242025-04-252024-04-26
自由现金流 $-420M——

我的指标 您的个人关注列表 — 来自完整基本面的选定行

📊

选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。

您的选择已保存，并会跟随您浏览所有股票。